Inhibikase Therapeutics Inc logo

Inhibikase Therapeutics Inc

NEW
STU:IQT0 (USA)   Ordinary Shares
€ 3.27 (0%) Jul 31
At Loss
P/B:
1.71
Market Cap:
€ 295.72M ($ 340.37M)
Enterprise V:
€ 219.68M ($ 252.84M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Inhibikase Therapeutics Inc Valuation Measures